Evidence map›Paper›PMID 31306099›Full record

ArticleAging2019

Identification of hub genes in prostate cancer using robust rank aggregation and weighted gene co-expression network analysis.

Zhen-Yu Song, Fan Chao, Zhiyuan Zhuo, Zhe Ma, Wenzhi Li, Gang Chen

Open access · greenAbstract readValidation Study
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Identification of the Key GeneInternational journal of molecular sciences · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhen-Yu SongDepartment of Urology, Jinshan Hospital of Fudan University, Shanghai, China.
Fan ChaoDepartment of Urology, Jinshan Hospital of Fudan University, Shanghai, China.
Zhiyuan ZhuoDepartment of Urology, Jinshan Hospital of Fudan University, Shanghai, China.
Zhe MaDepartment of Urology, Jinshan Hospital of Fudan University, Shanghai, China.
Wenzhi LiDepartment of Urology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Gang ChenDepartment of Urology, Jinshan Hospital of Fudan University, Shanghai, China.
Jinshan Hospital of Fudan University · CNShanghai Ninth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathogenic mechanisms of prostate cancer (PCa) remain to be defined. In this study, we utilized the Robust Rank Aggregation (RRA) method to integrate 10 eligible PCa microarray datasets from the GEO and identified a set of significant differentially expressed genes (DEGs) between tumor samples and normal, matched specimens. To explore potential associations between gene sets and PCa clinical features and to identify hub genes, we utilized WGCNA to construct gene co-expression networks incorporating the DEGs screened with the use of RRA. From the key module, we selected LMNB1, TK1, ZWINT, and RACGAP1 for validation. We found that these genes were up-regulated in PCa samples, and higher expression levels were associated with higher Gleason scores and tumor grades. Moreover, ROC and K-M plots indicated these genes had good diagnostic and prognostic value for PCa. On the other hand, methylation analyses suggested that the abnormal up-regulation of these four genes likely resulted from hypomethylation, while GSEA and GSVA for single hub gene revealed they all had a close association with proliferation of PCa cells. These findings provide new insight into PCa pathogenesis, and identify LMNB1, TK1, RACGAP1 and ZWINT as candidate biomarkers for diagnosis and prognosis of PCa.

Indexed as

Case-Control StudiesGene Expression ProfilingGTPase-Activating ProteinsHumansIntracellular Signaling Peptides and ProteinsLamin Type BMaleNuclear ProteinsOligonucleotide Array Sequence AnalysisProstatic NeoplasmsThymidine KinaseGTPase-Activating ProteinsIntracellular Signaling Peptides and ProteinsLamin Type BmgcRacGAPNuclear ProteinsThymidine Kinasethymidine kinase 1ZWINT protein, humanbioinformaticshub genesprostate cancerrobust rank aggregationweighted gene co-expression network analysis

Identifiers

PMID31306099
PMCPMC6660050
OpenAlexW2957094258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.